Jpmorgan Chase & CO Penumbra Inc Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Penumbra Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 131,028 shares of PEN stock, worth $38.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
131,028
Previous 384,142 65.89%
Holding current value
$38.2 Million
Previous $74.6 Million 58.28%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$190.97 - $253.66 $48.3 Million - $64.2 Million
-253,114 Reduced 65.89%
131,028 $31.1 Million
Q3 2024

Dec 26, 2024
BUY
$163.64 - $210.12 $11.3 Million - $14.5 Million
69,187 Added 21.97%
384,142 $74.6 Million
Q3 2024

Nov 08, 2024
BUY
$163.64 - $210.12 $11.3 Million - $14.5 Million
69,187 Added 21.97%
384,142 $74.6 Million
Q2 2024

Dec 26, 2024
SELL
$172.27 - $223.95 $11.9 Million - $15.5 Million
-69,187 Reduced 18.01%
314,955 $56.7 Million
Q2 2024

Aug 12, 2024
BUY
$172.27 - $223.95 $36.6 Million - $47.6 Million
212,345 Added 206.94%
314,955 $56.7 Million
Q1 2024

Dec 26, 2024
SELL
$220.09 - $273.15 $62 Million - $76.9 Million
-281,532 Reduced 73.29%
102,610 $22.9 Million
Q1 2024

May 10, 2024
BUY
$220.09 - $273.15 $6.52 Million - $8.09 Million
29,610 Added 40.56%
102,610 $22.9 Million
Q4 2023

Dec 26, 2024
SELL
$181.44 - $260.22 $56.5 Million - $81 Million
-311,142 Reduced 81.0%
73,000 $18.4 Million
Q4 2023

Feb 12, 2024
SELL
$181.44 - $260.22 $3.01 Million - $4.32 Million
-16,593 Reduced 18.52%
73,000 $18.4 Million
Q3 2023

Nov 14, 2023
SELL
$240.69 - $338.77 $7.55 Million - $10.6 Million
-31,365 Reduced 25.93%
89,593 $21.7 Million
Q2 2023

Aug 11, 2023
BUY
$271.54 - $344.06 $3.54 Million - $4.49 Million
13,036 Added 12.08%
120,958 $41.6 Million
Q1 2023

May 18, 2023
BUY
$220.43 - $278.69 $14.4 Million - $18.2 Million
65,290 Added 153.15%
107,922 $30.1 Million
Q1 2023

May 11, 2023
SELL
$220.43 - $278.69 $13.3 Million - $16.8 Million
-60,212 Reduced 58.55%
42,632 $11.9 Million
Q4 2022

Feb 13, 2023
SELL
$151.88 - $228.5 $154,158 - $231,927
-1,015 Reduced 0.98%
102,844 $22.9 Million
Q3 2022

Nov 14, 2022
BUY
$120.36 - $205.88 $574,959 - $983,488
4,777 Added 4.82%
103,859 $19.7 Million
Q2 2022

Aug 11, 2022
BUY
$116.09 - $227.33 $2.28 Million - $4.47 Million
19,657 Added 24.75%
99,082 $12.3 Million
Q1 2022

May 11, 2022
BUY
$187.51 - $283.98 $1.07 Million - $1.62 Million
5,711 Added 7.75%
79,425 $17.6 Million
Q4 2021

Feb 10, 2022
BUY
$238.08 - $288.0 $1.71 Million - $2.07 Million
7,179 Added 10.79%
73,714 $21.2 Million
Q3 2021

Nov 12, 2021
BUY
$250.72 - $291.24 $16.7 Million - $19.4 Million
66,535 New
66,535 $17.7 Million

Others Institutions Holding PEN

# of Institutions
409
Shares Held
29.2M
Call Options Held
254K
Put Options Held
43.3K
View Full List

About Penumbra Inc

PEN Quotes by TradingView
  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $11.1B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email